
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
Divisions of 1 Medical Oncology, 2 Imaging Research, 3 Clinical Trials and Epidemiology, and 4 Preventive Oncology and Departments of 5 Medical Imaging and 6 Medical Biophysics, Sunnybrook Health Sciences Centre and 7 Centre for Research in Women's Health, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada
Requests for reprints: Ellen Warner, Toronto-Sunnybrook Regional Cancer Center, Toronto, Ontario M4N 3M5, Canada. Phone: 416-480-4617; Fax: 416-480-6002. E-mail: ellen.warner{at}sunnybrook.ca
Background: Several observational studies have shown that magnetic resonance imaging (MRI) is significantly more sensitive than mammography for screening women over age 25 at high risk for hereditary breast cancer; however, MRI is more costly and less specific than mammography. We sought to determine the extent to which the low sensitivity of mammography is due to greater breast density.
Methods: Breast density was evaluated for all patients on a high-risk screening study who were diagnosed with breast cancer between November 1997 and July 2006. Density was measured in two ways: qualitatively using the four categories characterized by the Breast Imaging Reporting and Data System and quantitatively using a computer-aided technique and classified as (a)
10%, (b) 11% to 25%, (c) 26% to 50%, and (d) >50% density. Comparison of sensitivity of mammography (and MRI) for each individual density category and after combining the highest two and lowest two density categories was done using Fisher's exact test.
Results: A total of 46 breast cancers [15 ductal carcinoma in situ (DCIS) and 31 invasive] were diagnosed in 45 women (42 with BRCA mutations). Mean age was 48.3 (range, 32-68) years. Overall, sensitivity of mammography versus MRI was 20% versus 87% for DCIS and 26% versus 90% for invasive cancer. There was a trend towards greater mammographic sensitivity for invasive cancer in women with fattier breasts compared with those with greater breast density (37-43% versus 8-12%; P = 0.1), but this trend was not seen for DCIS.
Conclusion: It is necessary to add MRI to mammography for screening women with BRCA mutations even if their breast density is low. (Cancer Epidemiol Biomarkers Prev 2008;17(3):706–11)
This article has been cited by other articles:
![]() |
W. A. Berg Tailored Supplemental Screening for Breast Cancer: What Now and What Next? Am. J. Roentgenol., February 1, 2009; 192(2): 390 - 399. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |